05/22/2026
Research Technician Evan Nece delivered a research seminar at Trudeau Institute on developing next-generation antimicrobial therapeutics. The talk was entitled "Copper, Respiration, and Redox Stress: Defining the Mechanism of 2-Thiopyridinium Antituberculars.”
Evan is part of Dr. Michaelle Chojnacki's Innovative Therapeutics program which focuses on pathogens of critical clinical concern, such as Mycobacterium tuberculosis, nontuberculous mycobacteria and ESKAPE pathogens. Dr. Chojnacki's lab specializes in developing first-in-class therapies that target previously unexploited bacterial vulnerabilities.
Thank you to the Pittsfield Anti-Tuberculosis Association for their support of this work.